L. Chou

发表

DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity.

C. Chen, Y. Chao, Jen‐Shin Song, 2021, Life sciences.

Effect of micronization process on the functional component content and anti-inflammatory activity of Luffa cylindrical peel

T. Kao, L. Chou, Hsin-Lan Liu, 2016 .

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

C. Chen, Chien Ho, Yen-Ju Chen, 2020, Scientific Reports.

Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations.

C. Chen, Y. Chao, J. Hsu, 2015, European journal of medicinal chemistry.

Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).

C. Chen, Y. Chao, J. Hsu, 2011, Bioorganic & medicinal chemistry.

3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).

C. Chen, Y. Chao, J. Hsu, 2012, Bioorganic & medicinal chemistry letters.

Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model.

H. Hsieh, C. Chen, C. Shih, 2021, Journal of medicinal chemistry.

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer

C. Chen, Y. Chao, T. Yeh, 2014, PloS one.

Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells.

Hua-Lin Wu, L. Chou, Li‐Wha Wu, 2009, Cardiovascular research.

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

C. Chen, Chien Ho, Yen-Ju Chen, 2020, Scientific Reports.

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors (GISTs) and Acute Myeloid Leukemia (AML).

Yi-Hui Peng, C. Chen, Su-Ying Wu, 2019, Journal of medicinal chemistry.

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia.

Yi-Hui Peng, C. Chen, Su-Ying Wu, 2019 .

OP0133 PRECLINICAL EFFICACY OF R835, A NOVEL IRAK1/4 DUAL INHIBITOR, IN RODENT MODELS OF JOINT INFLAMMATION

V. Markovtsov, E. Masuda, S. Yi, 2020 .

Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).

C. Chen, Y. Chao, J. Hsu, 2013, Bioorganic & medicinal chemistry.